Trial Profile
Simvastatin addition to improve symptoms, cognition and metabolic syndrome in patients with recent-onset schizophrenia.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2020
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 14 Oct 2013 New trial record